Comparison of Adjuvant Monotherapy With Endocrine Therapy or Accelerated Partial Breast Irradiation Following Lumpectomy for Low Risk Breast Cancer Patients Over 65 (CAMERAN)
Conditions: Breast Cancer; Quality of Life Interventions: Radiation: Accelerated Partial Breast Irradiation (APBI); Drug: tamoxifen, anastrozole, exemestane, letrozole, fulvestrant, toremifene Sponsor: UNC Lineberger Comprehensive Cancer Center Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Arimidex | Breast Cancer | Breast Lumpectomy | Cancer | Cancer & Oncology | Endocrine Therapy | Lumpectomy | Research | Tamoxifen